Articles Tagged With:
-
Full October 2004 issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Assessing Blood Estradiol Levels
Vihtamaki and colleagues from Finland measured the circulating levels of estradiol 12 hours after the topical, percutaneous, evening administration of 1.5 mg estradiol (EstroGel) in 10 women who had been using this method of hormone therapy for at least 2 years. -
Special Report: Cesareans for All?
It is clear that the United States Cesarean section rate (CSR), while tailing off in the late 1990s, is now again rapidly heading upward. What Should be the Ideal CSR? Why the Recent Rise in CSR? Whos Most Apt to Either Offer or Comply with Patient-Requested Cesarean Section? -
Full September 29, 2004, Issue in PDF
-
Pharmacology Update: Duloxetine Hydrochloride Capsules (Cymbalta)
The FDA has approved duloxetine for the treatment of depression and the management of the pain associated with diabetic peripheral neuropathy. -
Clinical Briefs in Primary Care supplement
-
Understanding Immune Regulation in Multiple Sclerosis
NK cells may regulate activation of autoimmune memory T cells in an antigen non-specific fashion to maintain the clinical remission in CD95(+) NK-high multiple sclerosis patients. -
Full October 2004 Issue in PDF
-
Patient Handout: Herbal Supplements — Safety
Patient handout: Herbal supplements--Safety. Altern Med Alert 2004;7(10):S1-S2.